Introduction {#s1}
============

Polyheterocycles are organic molecules containing three or more heterocyclic moieties, which may be joined by one or more different kinds of connectivity (Ibarra et al., [@B27]). Nitrogen-containing polyheterocycles are of particular interest in the synthesis of bioactive molecules (Dener et al., [@B14]; Dolle et al., [@B17]; Atobe et al., [@B2]). Tris-heterocyclic molecules have been reported in optics and in coordination chemistry (Stibrany et al., [@B54]; Burling et al., [@B9]; Tahara et al., [@B56]).

The 4-substituted 1*H*-1,2,3-triazole is a heterocycle of high interest in medicinal chemistry, and it is well-documented that incorporation of this moiety into several bioactive compounds has resulted in advantages such as reduced toxicity or increased antibacterial or antimalarial activity (Shchepin et al., [@B52]; Zhou et al., [@B66]) \[e.g., [Figure 1](#F1){ref-type="fig"}, compound **A** (Dixit et al., [@B16])\]. Triazoles may also increase the stability and polarity of compounds by coordination of the N1 and N2 triazole nitrogens to active-site metal atoms in metalloproteases. The N3 nitrogen appears not to be directly involved in binding metals but can form hydrogen bonds with amino acid residues (Kallander et al., [@B34]; Huang et al., [@B26]; Röhri et al., [@B48]; Borkin et al., [@B8]). Additionally, 4-substituted 1*H*-1,2,3-triazoles are precursors of bioactive disubstituted 1,2,3-triazoles (Duan et al., [@B18]; Oh et al., [@B42]; Yan et al., [@B64]; Hsu et al., [@B25]; Bakulev and Beryozkina, [@B3]) and of pyridyl-1*H*-1,2,3-triazolate complexes that have applications in optics and coordination chemistry (Sinn et al., [@B53]; Prabhath et al., [@B44]). On the other hand, 1,4-disubstituted 1*H*-1,2,3-triazoles display structural and electronic similarities with the *trans*-amide bond. Their overall dipolar moment and hydrogen-bonding properties are greater than those of an amide bond, making these heterocycles effective peptidomimetics (Tron et al., [@B59]). These triazoles also function as flat bivalent elements, imitating the rigid conformational constraints of double bonds in alkyl chains. 1,4-Disubstituted 1*H*-1,2,3-triazoles are also capable substitutes for other five-membered nitrogen-containing heterocycles such as imidazoles, pyrazoles, 1,2,4-triazoles, oxazoles, isoxazoles, and oxazolidinones. Finally, these rings can act as more stable isosteres of phosphate linkers (Bonandi et al., [@B7]).

![Bioactive bis- and tris-heterocycles and our synthetic targets.](fchem-07-00546-g0001){#F1}

Common synthetic approaches to 4-substituted 1*H*-1,2,3-triazoles involve a \[3+2\] cycloaddition between sodium azide (NaN~3~) or hydrazoic acid (HN~3~) and terminal alkynes activated with electron-withdrawing groups (EWGs) (Hartzel and Benson, [@B22]; Balle et al., [@B4]; Blass et al., [@B5]; Koszytkowska-Stawińska et al., [@B35]). A variation of this classical methodology using trimethylsilyl azide (TMSN~3~) provides a much safer procedure. The use of a copper(I) catalyst allows the use of non-activated terminal alkynes in shorter reaction times and under milder conditions (Jin et al., [@B32]). For preparing 1,4-disubstituted 1-*H*-1,2,3-triazoles, the classic synthetic approach is the regiospecific copper-assisted \[3+2\] cycloaddition between terminal alkynes with organic azides (Rostovtsev et al., [@B49]; Tornøe et al., [@B57]). The most common technique is *in situ* reduction of copper(II) salts, such as CuSO~4~•5H~2~O or Cu(OAc)~2~, forming copper(I) salts using sodium ascorbate as the reducing agent. A second option is to use a copper(I) salt such as CuCl, CuBr, CuI, \[Cu(CH~3~CN)~4~\]OTf, or Cu(CH~3~CN)~4~PF~6~ in a deoxygenated environment and in organic solvent, typically with an amine such as TEA, DIEA, DIPEA, or PMDETA (Bock et al., [@B6]; Hein and Fokin, [@B24]; Lauria et al., [@B37]).

On the other hand, the fused heterocycle pyrrolo\[3,4-*b*\]pyridin-5-one is an aza-analog of isoindolin-1-one natural products and is present in several bioactive molecules; for example: hypoglycemic \[[Figure 1](#F1){ref-type="fig"}, compound **B** (Devasthale et al., [@B15])\], analgesic, anticancer, and therapeutic agents for CNS-related diseases like Alzheimer\'s, epilepsy, and schizophrenia (Unverferth et al., [@B61]; Chang et al., [@B11]; Pajouhesh et al., [@B43]; Lindsley et al., [@B38]). The synthesis of analogs with a brain-selective radioligand has also been reported \[[Figure 1](#F1){ref-type="fig"}, compound **C** (Wager et al., [@B62])\].

There are no previous reports of molecules containing 4-substituted or 1,4-disubstituted 1*H*-1,2,3-triazoles and pyrrolo\[3,4-*b*\]pyridin-5-ones, though there are a few examples of each of these ring systems connected to other heterocycles using multistep approaches \[[Figure 1](#F1){ref-type="fig"}, compounds **A**-**C**) (Dixit et al., [@B16]; Devasthale et al., [@B15]; Mallemula et al., [@B39]; Maračić et al., [@B40]; Wager et al., [@B62])\].

Isocyanide-based multicomponent reactions (IMCRs) are the most efficient strategies to synthesize pyrrolo\[3,4-*b*\]pyridin-5-ones, and Zhu first reported a one-pot synthesis in 2001 (Sun et al., [@B55]). We synthesized various annulated polyheterocycles containing this fused bis-heterocycle via IMCR strategies (Islas-Jácome et al., [@B29], [@B28]). However, there are no published reports of pyrrolo\[3,4-*b*\]pyridin-5-ones linked to other heterocycles in a non-annulated fashion using IMCRs. Recently, Van der Eycken reported a one-pot synthesis of disubstituted pyrrolo\[3,4-*b*\]pyridin-5-ones by an Ugi four-component reaction (Ugi-4CR)/carbocyclization/deacylation sequence ([Scheme 1](#S1){ref-type="scheme"}; Trang et al., [@B58]). While that work can generate oxidized 7-hydroxy derivatives, we sought a route that would feature improved atom economy, shorter reaction times, and milder conditions in addition to greater structural complexity with more functionalized products ([Scheme 1](#S1){ref-type="scheme"}).

![Previous works.](fchem-07-00546-g0002){#S1}

Besson reported the two-stage synthesis of tris-heterocycles with pyrido\[2,3-*d*\]pyrimidin-4(3*H*)-one linked to 1,2,3-triazoles via a one-pot DMFDMA-mediated cyclization followed by a CuAAC ([Scheme 1](#S1){ref-type="scheme"}; Hédou et al., [@B23]). However, only two heterocycles are constructed in this process and the scope of the alkynes is limited.

Our ongoing research program focuses on the design of rapid, convergent and efficient IMCR/post-transformation strategies toward novel molecules containing privileged heterocycles: azepino\[4,5-*b*\]indol-4-ones (Rentería-Gómez et al., [@B47]), 2-tetrazolylmethyl-isoindolin-1-ones (Rentería-Gómez et al., [@B46]), tetrazolo\[1,5-*a*\]quinolines (Unnamatla et al., [@B60]), 3-tetrazolylmethyl-azepino\[4,5-*b*\]indol-4-ones (Gordillo-Cruz et al., [@B21]), 2,3,4,9-tetrahydro-1*H*-β-carbolines (Cárdenas-Galindo et al., [@B10]), 4-(pyridine-3-yl)pyrimidines (Cortes-García et al., [@B12]), and spiro\[pyrrolidine-3,3′-oxindoles\] (Alvárez-Rodríguez et al., [@B1]). Herein we describe the first cascade IMCR process/post-transformation strategy toward the synthesis of 4-substituted 1*H*-1,2,3-triazoles linked to a fused, bis-heterocyclic peptidomimetic. A key aspect of this work is that the cascade IMCR process rapidly generates a complex alkyne for the subsequent \[3+2\] cycloaddition ([Scheme 2](#S2){ref-type="scheme"}).

![Cascade IMCR /\[3+2\] cycloaddition strategy.](fchem-07-00546-g0003){#S2}

Results and Discussion {#s2}
======================

In this work, we report the two-step synthesis of compounds **9a**-**m** and **19a-d**, which contain three different heterocycles: pyridine, pyrrolidin-2-one, and 1*H*-1,2,3-triazole (4-substituted and 1,4-disubstituted) ([Scheme 3](#S3){ref-type="scheme"}). The use of orthogonal, bifunctional reagents plays a central role in the IMCR/post-transformation strategy, leading to the rapid generation of molecular complexity in both bis-heterocycles **6a**-**m** and final products **9a**-**l**. In the first step, the synthesis of **6a**-**m** occurs by a cascade process combining an Ugi-3CR with aza Diels-Alder, *N*-acylation, and aromatization reactions to give a complex terminal alkyne functionalized at the α-position with a fused bis-heterocycle. Two fused rings were created in the process, resulting in pyrrolo\[3,4-*b*\]pyridin-5-ones **6a**-**m**.

![Synthesis of 4-substituted 1*H*-1,2,3-triazoles **9a-l** and 1,4-disubstituted 1*H*-1,2,3-triazoles **19a-l** via an IMCR/aza Diels-Alder/*N*-acylation/aromatization/\[3+2\] cycloaddition sequence.](fchem-07-00546-g0004){#S3}

To optimize the cascade process, we attempted to synthesize complex alkyne **6a** by sequentially reacting propargylamine (**1**), benzaldehyde (**2a**), isocyanide **3a**, and maleic anhydride (**4**) using toluene ([Table 1](#T1){ref-type="table"}). Performing the reaction without catalyst at 60--80 °C under conventional conditions produced **6a** in 13% yield (entry 1, [Table 1](#T1){ref-type="table"}). When the reaction was carried out using catalytic amounts of NH~4~Cl at 60--80 °C (Janvier et al., [@B31]), the product was isolated in 43% yield (entry 2, [Table 1](#T1){ref-type="table"}). Under microwave conditions, the yield increased to 57% (entry 3, [Table 1](#T1){ref-type="table"}). In previous reports, we used TsOH for the aromatization process after a Diels-Alder cycloaddition to construct the isoindolin-1-one moiety (Rentería-Gómez et al., [@B46]). Unfortunately, bis-heterocycle **6a** was not detected when TsOH was used; only decomposition was observed by TLC.

###### 

IMCR based cascade strategy screening conditions.

  ![](fchem-07-00546-i0001.jpg)                                                                                                                        
  ------------------------------- ---------- -------------------------------------------------- -------------------------------------------- --------- --------
  1                               PhMe       -------                                            65--80                                       12        13
  2                               PhMe       NH~4~Cl[^c^](#TN3){ref-type="table-fn"}            65--80                                       12        43
  3                               PhMe       NH~4~Cl[^c^](#TN3){ref-type="table-fn"}            65--80[^d^](#TN4){ref-type="table-fn"}       1.5       57
  4                               PhMe       TsOH[^e^](#TN5){ref-type="table-fn"}               65-80[^d^](#TN4){ref-type="table-fn"}        1.5       ---
  5                               PhMe       Sc(OTf)~3~[^f^](#TN6){ref-type="table-fn"}         65--80                                       12        42
  **6**                           **PhMe**   **Sc**$\mathbf{(OTf)}_{\mathbf{3}}^{\mathbf{f}}$   **65--80**[^d^](#TN4){ref-type="table-fn"}   **1.5**   **69**
  7                               PhMe       Yb(OTf)~3~[^f^](#TN6){ref-type="table-fn"}         65-80[^d^](#TN4){ref-type="table-fn"}        1.5       62

*1.0 equiv. **1**, 1.0 equiv. **2a**, 1.2 equiv. **3a**, 1.4 equiv. **4***.

*1.0 mL solvent*.

*1.4 equiv*.

*MW (100 W)*.

*1.5 equiv*.

*3.0 mol%*.

*isolated products*.

*Bold values indicate the best conditions*.

Using catalytic Sc(OTf)~3~ under conventional heating, **6a** was obtained in 42% yield (entry 5, [Table 1](#T1){ref-type="table"}). Microwave heating with Sc(OTf)~3~ or Yb(OTf)~3~ (Islas-Jácome et al., [@B29], [@B28]) raised the yield to 69 and 62%, respectively (entries 6-7, [Table 1](#T1){ref-type="table"}). We therefore used the optimal conditions (entry 6: 3 mol% Sc(OTf)~3~, microwave heating 60--80 °C, 1.5 h) to synthesize the series of fused bis-heterocycles **6a**-**l** ([Table 2](#T2){ref-type="table"}).

###### 

Synthesis of the 6-propargyl-pyrrolo\[3,4-*b*\]pyridin-5-ones **5a-l**.

  ![](fchem-07-00546-i0002.jpg)                                
  ------------------------------- ------------- -------------- ----
  **6a**                          Ph            piperidine     64
  **6b**                          3,4-diOMePh   piperidine     72
  **6c**                          4-FPh         piperidine     62
  **6d**                          *n*-hexyl     piperidine     64
  **6e**                          Ph            morpholine     69
  **6f**                          3,4-diOMePh   morpholine     66
  **6g**                          4-FPh         morpholine     66
  **6h**                          *n*-hexyl     morpholine     67
  **6i**                          Ph            diethylamine   59
  **6j**                          3,4-diOMePh   diethylamine   63
  **6k**                          4-FPh         diethylamine   64
  **6l**                          *n*-hexyl     diethylamine   66

*Reactions performed with 1.0 equiv. propargylamine (**1**), 1.0 equiv. aldehyde **2a-d**, 1.2 equiv. isocyanide **3a-c**, 1.4 equiv. maleic anhydride (**4**), 3 mol% Sc(OTf)~3~, 1 mL PhMe*.

*isolated products*.

The scope of this cascade process was explored using alkyl and aryl aldehydes **2a**-**d** and amide-containing isocyanides **3a**-**c** ([Table 2](#T2){ref-type="table"}). The role of fluorine atoms in improving bioavailability, lipophilicity and metabolic resistance in bioactive molecules is well-documented (Purser et al., [@B45]). The products **6c**, **6g**, and **6k** containing fluorine atom was synthesized. Piperidine, morpholine, and diethylamine were incorporated as substituents of isocyanides **3a-c**. These fragments can act as structural bioisosteres, preferably interacting with some amino acids allowing in some cases improve biological activity (Kalinsky and Weinstein, [@B33]; Sander et al., [@B50]; Meng et al., [@B41]; El-Nassan, [@B19]; Yu et al., [@B65]; Sato et al., [@B51]).

The highest yield (72%) was obtained for product **6b**, which contains 2,3-dimethoxyphenyl and piperidine as substituents at R^1^ and R^2^, respectively. Contrarily, bis-heterocycle **6i**, with phenyl and diethylamine substituents, was obtained in the lowest yield (59%). In fact, among all products, the diethylamine-containing analogs **6i**-**l** were synthesized in lower yields, which can be attributed to the lower stability of this isocyanide in acidic media. In all cases, the primary byproducts were the corresponding 5-aminooxazoles resulting from Lewis-acid-catalyzed chain-ring tautomerization of the isocyanides **3a**-**c** (Gao et al., [@B20]). Consistent with reports by Zhu (Cuny et al., [@B13]; Wang et al., [@B63]), we also observed, as minor byproducts, the alcohols resulting from isocyanide addition to the aldehydes prior to oxazole formation (**7)** ([Scheme 4](#S4){ref-type="scheme"}). The plausible reaction mechanism for the formation of pyrrolo\[3,4-*b*\]pyridin-5-ones **6a**-**l** is supported by computational calculations performed previously using DFT methods ([Scheme 4](#S4){ref-type="scheme"}) (Islas-Jácome et al., [@B30]).

![Plausible reaction mechanism.](fchem-07-00546-g0005){#S4}

Conditions were screened for the \[3+2\] cycloaddition using terminal alkyne **6a** ([Table 3](#T3){ref-type="table"}). Heating at 100 °C for 12 h with 1.0 equiv. TMSN~3~ and 3 mol% CuI provided tris-heterocycle **9a** in a modest 48% yield (entry 1, [Table 2](#T2){ref-type="table"}). Increasing the equivalents of the volatile TMSN~3~ to 1.5 or 2.0 raised the yield of **9a** to 69 and 77%, respectively (entries 2-3, [Table 2](#T2){ref-type="table"}). Using additional CuI (5% mol) and increasing the reaction time to 18 h did not improve the yield (entry 4, [Table 2](#T2){ref-type="table"}). Microwave heating reduced both the reaction time and the yield to 52%, as high amounts of byproducts were detected (entry 5, [Table 2](#T2){ref-type="table"}).

###### 

Screening conditions for the \[3+2\] cycloaddition.

  ![](fchem-07-00546-i0003.jpg)                                                                     
  ------------------------------- --------- ------- -------------------------------------- -------- --------
  1                               1.0       3       100                                    12       48
  2                               1.5       3       100                                    12       69
  **3**                           **2.0**   **3**   **100**                                **12**   **77**
  4                               2.0       5       100                                    18       75
  5                               2.0       3       100[^b^](#TN11){ref-type="table-fn"}   0.5      52

*isolated products*.

*MW (100 W)*.

*Bold values indicate the best conditions*.

Using the optimized conditions, a series of tris-heterocycles (**9a**-**l**) was synthesized from complex alkynes **6a**-**I** via the \[3+2\] cycloaddition in good yields (70--80%, [Table 4](#T4){ref-type="table"}). The highest yields were obtained for the 4-fluorophenyl analogs. Alkynes **6a**-**l** and triazole products **9a**-**l** were fully characterized by IR, ^1^H and ^13^C NMR, and HRMS (see the [Supplementary Material](#SM1){ref-type="supplementary-material"} for further details). Several attempts to obtain adequate crystals for X-ray analysis were performed without success.

###### 

Synthesis of 4-substituted 1*H*-1,2,3-triazoles **9a-l**.

  ![](fchem-07-00546-i0004.jpg)                                
  ------------------------------- ------------- -------------- ----
  **9a**                          Ph            piperidine     77
  **9b**                          3,4-diOMePh   piperidine     75
  **9c**                          4-FPh         piperidine     80
  **9d**                          *n*-hexyl     piperidine     70
  **9e**                          Ph            morpholine     63
  **9f**                          3,4-diOMePh   morpholine     73
  **9g**                          4-FPh         morpholine     80
  **9h**                          *n*-hexyl     morpholine     75
  **9i**                          Ph            diethylamine   73
  **9j**                          3,4-diOMePh   diethylamine   70
  **9k**                          4-FPh         diethylamine   78
  **9l**                          *n*-hexyl     diethylamine   75

*1.0 equiv. alkyne **6a**-**l**, 2.0 equiv. TMSN~3~, 3% mol CuI in MeOH/DMF (9:1 v/v, 0.5 M) at 100 °C for 12 h*.

*isolated products*.

In [Scheme 5](#S5){ref-type="scheme"}, we show a plausible reaction mechanism for the alkyne-azide \[3+2\] cycloaddition to produce 4-substituted 1*H*-1,2,3-triazoles. The reaction likely proceeds through the formation of copper acetylide species **13a**-**l** from terminal alkynes **6a**-**l** with CuI (**12**) and *in situ* generation of HN~3~ (**17**) from the reaction of TMSN~3~ (**15**) and MeOH (**14**). Copper-assisted cycloaddition between **13a**-**l** and HN~3~ (**17**) takes place to form intermediates **18a**-**l**. Protonolysis of the C-Cu bond of **18a**-**l** by terminal alkynes **6a**-**l**, HI, or MeOH affords 4-substituted 1*H*-1,2,3-triazoles **9a**-**l** (Jin et al., [@B32]).

![Plausible CuAAC reaction mechanism.](fchem-07-00546-g0006){#S5}

Having the methodology for the synthesis of compounds **9a-l**, we next explored the scope of use de terminal alkynes linked to bis-heterocycles using organic azides to obtain the 1,4-disubstituted 1,2,3-triazoles (**19a-d**) via CuAAC. Compound **6m** was synthetized (60% yield) and selected as model. Phenyl azides with different stereo-electronic natures (**20a-d**) were prepared from aromatic amines via diazotization with sodium nitrite in water in the presence of p-TsOH followed by reaction with sodium azide at room temperature (Kutonova et al., [@B36]).

First, the reaction was carried out under constant stirring, at room temperature, using **6m** and azide **20a** obtaining an 85% yield of 1,4-disubstituted 1,2,3-triazole **19a** after 5 h. When the reaction was carried out using ultrasound-assisted irradiation (USI) at room temperature, the product **19a** was obtained in 1.5 h, with a yield of 83%. For this reason, we decided to use the USI protocol for the synthesis of 1,4-disubstituted 1-*H*-1,2,3-triazoles (**19a-d**). The reactions under USI resulted in reduced reaction times (30--90 min) and good yields (83--93%) in the CuAAC for the synthesis of **19a-e** ([Table 5](#T5){ref-type="table"}).

###### 

Synthesis of 1,4-disubstituted 1*H*-1,2,3-triazoles **19a-e**.

  ![](fchem-07-00546-i0005.jpg)                                        
  ------------------------------- ------------------------------- ---- ----
  **19a**                         ![](fchem-07-00546-i0006.jpg)   90   83
  **19b**                         ![](fchem-07-00546-i0007.jpg)   30   89
  **19c**                         ![](fchem-07-00546-i0008.jpg)   45   93
  **19d**                         ![](fchem-07-00546-i0009.jpg)   45   90

*1.0 equiv. azide **20a**-**e**, 5% mol Cu~2~$\text{SO}_{4}^{*}$5H~2~O, 20% mol Na-ascorbate in H~2~O/tert-BuOH (1:1 v/v, 0.3 M) at rt (USI) for 30-90 min*.

*isolated products*.

Conclusions {#s3}
===========

We have developed a new and efficient strategy to synthesize 4-substituted and 1,4-disubstituted 1*H*-1,2,3-triazoles linked to pyrrolo\[3,4-*b*\]pyridin-5-ones. Molecules containing these heterocycles together are novel. The molecules synthesized contain privileged tris-heterocycles which could have applications in medicinal chemistry and coordination chemistry.

The IMCR based cascade process coupled with CuAAC strategy, as convergent and powerful tool toward the synthesis of bis and tris heterocycles is unreported.
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